Atypical presentations include isolated fatigue, depression, gastrointestinal symptoms, or urinary complaints without obvious menstrual correlation
UsesDirections for UseRoute of AdministrationSide EffectsMedicine ActivityPrecautions & WarningsInteractionsDosageStorageSpecial Dietary And Lifestyle RecommendationFact BoxFAQs KARNITINE INJECTION 5ML is used for the following: Primary and secondary carnitine deficiency, particularly in patients with end-stage renal disease undergoing haemodialysis As supportive therapy in certain fatigue-related conditions To use KARNITINE INJECTION 5ML, follow the instructions below: It should only be administered under the supervision of a healthcare professional
Preclinical studies suggest that GLP-1RAs have a beneficial effect on major NAFLD histological outcomes, i.e., hepatic steatosis and inflammation, through multiple intrahepatic mechanisms, including increased fatty acid -oxidation, activation of autophagy, suppression of inflammation, and oxidative stress
The dramatic report by the WHO has shown that by 2050, drug resistance could catch up to cancer and sufficiently damage the economy if actions are not taken (World Health Organization, 2019)
A deficiency of vitamin B12, therefore, results in reduced production and maturation of cells with high turnover particularly red blood cells
Eligible patients include those with severe obesity and a body mass index (BMI) of at least 40 kg/m, as well as those with serious obesity and a BMI of at least 35 kg/m
